1941 |
|
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with leishmania major
|
Gurunathan, S
|
Rockefeller University Press
|
1980
|
|
|
1942 |
|
Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response
|
Bishop, S. A
|
Butterworths
|
1996
|
|
|
1943 |
|
Vaccination with Novel Immunostimulatory Adjuvants against Blood-Stage Malaria in Mice/
|
Su, Z
|
American Society for Microbiology
|
2003
|
|
|
1944 |
|
Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response
|
Kwak, L. W
|
National Academy of Sciences[etc.]
|
1980
|
|
|
1945 |
|
Vaccination with Toxoplasma gondii SAG-1 Protein Is Protective against Congenital Toxoplasmosis in BALB/c Mice but Not in CBA/J Mice/
|
Letscher-Bru, V
|
American Society for Microbiology
|
2003
|
|
|
1946 |
|
Vaccinator device for delivering propellant-driven aerosols of Streptococcus suis bacterin into the respiratory tracts of swine
|
Brown, A. R
|
Butterworths
|
1997
|
|
|
1947 |
|
Vaccine
중앙도서관 대출불가(별치)
|
|
Butterworths
|
1983-
|
|
|
1948 |
|
`Vaccine-associated' feline sarcoma/
|
Lewis, H. B
|
The Association
|
2003
|
|
|
1949 |
|
Vaccine coverage of Streptococcus pneumoniae in Hong Kong with attentionto the multiple-antibiotic-resistant strains
|
Kam, K. M. Luey, K. Y.
|
Butterworths
|
1996
|
|
|
1950 |
|
Vaccine Development: from Empirical Medicine to Molecularly Designed Therapy/
|
Buschle, Michael
|
|
2001
|
|
|
1951 |
|
Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo
|
Beer, B
|
National Academy of Sciences[etc.]
|
1980
|
|
|
1952 |
|
Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP/
|
Hohdatsu, T
|
Elsevier Scientific Pub. Co
|
2003
|
|
|
1953 |
|
Vaccine Efficacy of a Lysine Auxotroph of Mycobacterium tuberculosis/
|
Pavelka, M. S
|
American Society for Microbiology
|
2003
|
|
|
1954 |
|
Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8^+ T cells: implications for vaccine development in immune-deficient hosts/
|
Wuthrich, M
|
Rockefeller University Press
|
2003
|
|
|
1955 |
|
Vaccine-Induced Protection against Helicobacter pylori in Mice Lacking Both Antibodies and Interleukin-4/
|
Garhart, C. A
|
American Society for Microbiology
|
2003
|
|
|
1956 |
|
Vaccine institute treads wary path
|
|
Macmillan Journals ltd., etc.]
|
1997
|
|
|
1957 |
|
Vaccine-makers and Ebola Giving it a shot
|
unknown
|
Economist Newspaper Ltd
|
2014
|
|
|
1958 |
|
Vaccine Platform Technologies: A Potent Tool for Emerging Infectious Disease Vaccine Development
|
Amesh A. Adalja ; Matthew Watson ; Anita Cicero ; Tom Inglesby
|
Mary Ann Liebert
|
2020
|
|
|
1959 |
|
Vaccine Platform Technologies: A Potent Tool for Emerging Infectious Disease Vaccine Development
|
Amesh A. Adalja, Matthew Watson, Anita Cicero, and Tom Inglesby
|
Mary Ann Liebert
|
2020
|
|
|
1960 |
|
Vaccine Prepared from Chicken Embryo Cultures for Immunization Against Smallpox
|
Coffey, Julia M
|
|
1934
|
|
|